Lancet

• Latest
• Best
• Search…

• Lancet · Jun 2018

  Response to the Ebola virus disease outbreak in the Democratic Republic of the Congo.

  no abstract available

  read more… mark as read…

• Lancet · Jun 2018

  Comment

  Long-term albumin in cirrhosis: is it the ANSWER?

  no abstract available

  read more… or just mark as read…

• Lancet · Jun 2018

  Editorial Comment

  Untangling the complications of diabetes.

  no abstract available

  explore further… or not…

• Lancet · Jun 2018

  Comment Letter

  Accelerating the evidence for new classes of long-lasting insecticide-treated nets.

  no abstract available

  explore further… mark as read…

• Lancet · Jun 2018

  Randomized Controlled Trial Multicenter Study Pragmatic Clinical Trial

  Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.

  Evidence is scarce on the efficacy of long-term human albumin (HA) administration in patients with decompensated cirrhosis. The human Albumin for the treatmeNt of aScites in patients With hEpatic ciRrhosis (ANSWER) study was designed to clarify this issue. ⋯ Italian Medicine Agency.

  read more… or not…